Jon Hamrick, MBA, Appointed as Therigy's Chief Strategy Officer

​With the specialty pharmacy industry moving into the New Year, Therigy, the developer of TherigySTM, the pharmacy industry’s leading specialty therapy management software platform, continues to expand its legacy as the go-to, trusted source for specialty solutions. As part of its 2017 growth strategy, and to set the foundation to deliver even more powerful technology, outcomes measurement, and reporting solutions to its specialty pharmacy stakeholders at a global level, Therigy today announced the promotion of Jon Hamrick, MBA to the role of Chief Strategy Officer.

In his role as Therigy’s Chief Strategy Officer, Hamrick will drive continuous product and technology innovation through strategy development, market expansion, and a network of partnerships and alliances with pharma manufacturers, technology developers, and other analytics and outcomes partners. Further, Hamrick will lead the charge to extend Therigy’s specialty solutions to international healthcare organizations. In addition, he will retain his responsibility in leading Therigy’s pharma consulting division. 

“Therigy has evolved from a consultancy that provided expert guidance to a largely new and unknown specialty pharmacy sector into a technology company that provides the therapy management platform of choice for what is now one of healthcare’s fastest evolving industries,” explained Russel Allinson, RPh, MS, Therigy’s CEO and Chief Clinical Officer. “Jon’s strategic vision, experience, and insights in pharmacy innovation have continually played a significant role in the high value we deliver to our customers. In his expanded role as Chief Strategy Officer, he will continue to build on that value by developing and implementing a robust strategy to enhance our market position on a global level.”

Hamrick joined Therigy as a Principal Partner in 2011, bringing with him more than 25 years of pharma, medical device, payer industry, and senior leadership experience. Prior to his appointment as Chief Strategy Officer, he was Therigy’s Executive Vice President of Biotech & Specialty Services, where he led the company’s pharma consulting practice, sales, marketing, client services and corporate business development activities. Before joining Therigy, Hamrick was Vice President of Business Development at Priority Healthcare. He went on to be a senior member of the leadership team at CuraScript, a subsidiary of Express Scripts.

Hamrick earned his Bachelor of Arts degree in History from the University of Central Florida, and an MBA from the University of Florida Warrington College of Business. Prior to entering the healthcare industry, he served as a U.S. Marine Corps infantry officer. He is also a noted speaker, presenter, and moderator at specialty pharmacy conferences across the U.S.

About Therigy

Therigy is the trusted source for innovative, best-in-class software and expert consulting services to the specialty pharmaceutical market. Clients leverage Therigy’s solutions, data, and insights to achieve clinical and economic success by aligning strategy, technology, and people. Learn more about Therigy at www.therigy.com.

About TherigySTM

TherigySTM is used by leading specialty pharmacies to provide superior care and therapy-specific clinical support, maximize adherence, and improve outcomes.  The application allows for accurate and reliable data collection and outcomes reporting.  The product easily integrates with pharmacy dispensing systems.  Most importantly, Therigy has configured more than 253 clinical assessments into TherigySTM to provide a turnkey application that requires little if any additional clinical development by the subscriber. To our knowledge, TherigySTM is the only pharmacy care management system on the market which is pre-configured with clinical content and for which the subscription price includes regular releases of new content for new drugs, new indications, and changes to prescribing information.  In addition, Therigy has created the capability for easy customization of content and even complete protocols by the subscriber.